Stockscreener 앱 받기
40.46
0.47%
0.2017
Royalty Pharma Plc 주식(RPRX)의 최신 뉴스
Royalty Pharma increases quarterly dividend by 6.8% to $0.235 - Investing.com India
Royalty Pharma Increases Quarterly Dividend to $0.235 a Share From $0.22, Payable March 10 to Holders of Record on Feb. 20. - MarketScreener
Royalty Pharma Declares Q1 2026 Dividend of $0.235 per Share, Marking 6.8% Increase - Quiver Quantitative
Royalty Pharma raises quarterly dividend by 6.8% to $0.235/share - MSN
Royalty Pharma Announces Dividend Increase - The Manila Times
Royalty Pharma plc (RPRX) Raises Quarterly Dividend 7.3% to $0.235; 2.3% Yield - StreetInsider
Royalty Pharma Announces Dividend Increase - Benzinga
Moran Wealth Management LLC Increases Position in Royalty Pharma PLC $RPRX - MarketBeat
Is Royalty Pharma plc stock supported by strong cash flowsInflation Watch & Stock Timing and Entry Methods - ulpravda.ru
Royalty Pharma buys remaining royalty interest in Roche drug Evrysdi - MSN
Is Royalty Pharma plc stock affected by interest rate hikesJuly 2025 Opening Moves & Growth Oriented Trade Recommendations - ulpravda.ru
Trade Report: How risky is Royalty Pharma plc (RPD) stock compared to peersPortfolio Value Summary & Free Expert Verified Stock Movement Alerts - ulpravda.ru
Is Royalty Pharma plc stock ready for breakoutJuly 2025 Technicals & Short-Term Swing Trade Alerts - ulpravda.ru
170,604 Shares in Royalty Pharma PLC $RPRX Bought by Hosking Partners LLP - MarketBeat
Royalty Pharma PLC $RPRX Shares Bought by Robeco Institutional Asset Management B.V. - MarketBeat
Royalty Pharma stock hits 52-week high at $41.26 By Investing.com - Investing.com Nigeria
Royalty Pharma stock hits 52-week high at $41.26 - Investing.com India
Royalty Pharma (NASDAQ:RPRX) Sets New 1-Year HighHere's Why - MarketBeat
Royalty Pharma shares edge higher on acquisition of oncology drug royalties - MSN
United StatesGoodwin Guides Royalty Pharma On Acquisition Of Remaining Royalty Interest In Roche’s Evrysdi For $240 Million And Potential Milestones - Mondaq
Royalty Pharma plc (NASDAQ:RPRX) Nasdaq Index Life Sciences Partner - Kalkine Media
Financiere des Professionnels Fonds d investissement inc. Invests $933,000 in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma Acquires Remaining Royalty Interest in Roche’s Evrysdi for $240 Million and Potential Milestones - citybiz
Why (RPRX) Price Action Is Critical for Tactical Trading - Stock Traders Daily
What's Going On With Royalty Pharma Stock Wednesday?Royalty Pharma (NASDAQ:RPRX) - Benzinga
Royalty Pharma Acquires Remaining Royalty Interest in Roche's Evrysdi for $240 Million and Potential Milestones - MarketScreener
Royalty Pharma Acquires Remaining Evrysdi Royalties From PTC Therapeutics - Nasdaq
Royalty Pharma acquires final portion of Evrysdi royalty for $240 million By Investing.com - Investing.com Nigeria
PTC Therapeutics IncCo, Royalty Pharma Inv - 富途牛牛
Royalty Pharma acquires remaining royalty interest in Roche's Evrysdi for $240 million - MarketScreener
Royalty Pharma Buys Remaining Royalty Interest in Roche's Evrysdi - MarketScreener
Royalty Pharma acquires final portion of Evrysdi royalty for $240 million - Investing.com
Royalty Pharma (NASDAQ:RPRX) EVP Sells $786,400.00 in Stock - MarketBeat
Royalty Pharma stock rises after acquiring full Evrysdi royalty By Investing.com - Investing.com Canada
Royalty Pharma stock rises after acquiring full Evrysdi royalty - Investing.com
Royalty Pharma Acquires Final Portion of Evrysdi Royalty from PTC Therapeutics for $240 Million - Quiver Quantitative
Royalty Pharma acquires remaining Evrysdi royalty for $240 million - StreetInsider
A $1.9B spinal atrophy drug’s royalties just found a new owner - Stock Titan
Nuvalent’s royalty interest acquired by Royalty Pharma - MSN
Royalty Pharma PLC $RPRX Shares Sold by Marathon Asset Management Ltd - MarketBeat
Royalty Pharma announces planned legal leadership transition - MSN
Royalty Pharma Plc's (NASDAQ:RPRX) Earnings Haven't Escaped The Attention Of Investors - 富途牛牛
World Investment Advisors Takes $1.70 Million Position in Royalty Pharma PLC $RPRX - MarketBeat
Can Royalty Pharma plc (RPD) stock ride next bull market cycleReal Estate Investment Trusts & Capitalize On Fast Trends - bollywoodhelpline.com
Royalty Pharma PLC $RPRX Stock Holdings Lifted by Voya Investment Management LLC - MarketBeat
Swedbank AB Acquires 42,800 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Friedenthal Financial Acquires Shares of 29,322 Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma (RPRX): Reassessing Valuation After MYQORZO’s FDA Approval Unlocks New Royalty Cash Flows - Sahm
Royalty Pharma (NASDAQ:RPRX) EVP Sells $767,600.00 in Stock - MarketBeat
Royalty Pharma Announces Planned Legal Leadership Transition - TipRanks
Royalty Pharma names McGivern as chief legal officer - StreetInsider
0.86%
자본화:
|
볼륨(24시간):